Nosocomial infections in acute leukemia: Comparison between younger and elderly patients

New Microbiologica

Volumn 31, Issue 1, 2008, Pages 89-96

  Fanci, Rosa ^a   Leoni, Franco ^a   Longo, Giovanni ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Acute leukemia; Elderly leukemia; Nosocomial infections; Younger leukemia

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; AGING; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; CROSS INFECTION; FEMALE; FUNGUS; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOLOGY; ISOLATION AND PURIFICATION; LEUKEMIA; LYMPHATIC LEUKEMIA; MALE; MICROBIOLOGY; MIDDLE AGED; MYCOSIS;

ADULT; AGED; AGING; BACTERIAL INFECTIONS; CROSS INFECTION; FEMALE; FUNGI; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LEUKEMIA; LEUKEMIA, MYELOID, ACUTE; MALE; MIDDLE AGED; MYCOSES; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

NIA;

EID: 41049093812     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. ASCIOGLU S., REX J.H., DE PAUW B., BENNET I.E., BILLE, J., CROKAERT F., DENNING D.W., DONNELLY J.P., EDWARDS J.E., FRIAVEC Z., FIERE D., LORTHOLARY O., MAERTENS J., MEIS J.F., PATTERSON T.F., RITTER J., SELLESLAG D., SHAH P.M., STEVENS D.A., WALSH T.J. INVASIVE FUNGAL INFECTIONS COOPERATIVE GROUP OF THE EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER; MYCOSES STUDY GROUP OF THE NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES. (2002). Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin. Infect. Dis. 34 (1), 7-14.
2. BOCHUD P.Y., EGGIMAN P., CALANDRA T., VAN MELLE G., SAGHAFI G., FRANCIOLI P. (1994). Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clin. Infect. Dis. 18(1), 25-31.
3. BOEHMER E.D., GORAL J., FAUNCE D.E., KOVACS E.J. (2004). Age - dependent decrease in Toll-like receptor 4-mediated proinflammatory cytokine production and mitogen-activated protein kinase expression. J. Leucoc. Biol. 75 (2), 342-349.
4. Brakhage AA. (2005). Systemic fungal infections caused by Aspergillus species: epidemiology, infection progress and virulence determinants. Curr. Drug Targets. 6 (8), 875-876.
5. BUCHNER T., HIDDEMANN W., BERDEL W.E., WORMANN B., SCHOCH C., FONATSCH C., LOFFLER H., HAFERLACH T., LUDWIG W.D., MASCHMEYER G., STAIB P., AUL C., GRUNEISEN A., LENGFELDER E., FRICKHOFEN N., KERN W., SERVE H.L., MESTERS R.M., SAUERLAND M.C., HEINECKE A. GERMAN A.M.L. COOPERATIVE GROUP ET AL. (2003). Thioguanine, cytarabine and daunorubicin (TAD) and high-dose cytarabine and mitoxantrone (HAM) for induction, TAD for consolidation, and either prolonged maintenance by reduced montly TAD or TAD-HAM-TAD and one course of intensive consolidation by sequential HAM in adult patients at all ages with de novo acute myeloid leukemia (AML): a randomized trial of the German AML Cooperative group. J. Clin. Oncol 15, 21 (24), 4496-4504.
6. CHERNOBELSKI P., LAVRENKOV K., RIMAR D., RIESENBERG K., SCHLAEFFER F., ARIAD, S., MERMERSHTAIN, W. (2006). Prospective study of empiric monotherapy with ceftazidime for low-risk grade IV febrile neutropenia after cytotoxic chemotherapy in cancer patients. Chemotherapy. 52 (4), 185-189.
7. FALCONE M., MICOZZI A., POMPEO M.E., BAIOCCHI P., FABI F, PENNI A., MARTINO P., VENDITTI, M. (2004). Methicillin-resistant staphylococcal bacteraemia in patients with hematologic malignancies: clinical and microbiological retrospective comparative analysis of S. haemoliticus, S. epidermidis and S. aureus J. Chemother. 16 (6), 540-548.
8. FANCI R., PECILE P., FABBRI A., PACI C., MARTINEZ R.L., LONGO G. (1999). Emerging infections due to enterococci in patients with acute leukemia. Haematologica. 84 (7), 662-664.
9. FANCI R., PACI C., PECILE P. (2001). Isolation frequency and antimicrobial susceptibility of Pseudomonas aeruginosa bloodstream infections in neutropenic patients with acute leukemia. J. Chemother. 13 (2), 213-215.
10. FANCI R., PACI C., ANICHINI P., PECILE P., MARRA G., CASINI C., NICOLETTI P. (2003). Incidence and molecular epidemiology of Pseudomonas aeruginosa bacteremia in patients with acute leukemia: analysis by pulsed-field gel electrophoresis. (2003). New Microbiol. 26(4), 353-361.
11. FREIFELD A., WALSH T., MARSHALL D., GRESS J., STEINBERG S.M., HATHORN J., RUBIN M., JAROSINSKI P., GILL V., YOUNG R.C., PIZZO P.A. (1995). Monotherapy for fever and neutropenia in cancer patients: a randomized comparison of ceftazidime versus imipenem. J. Clin. Oncol. 13 (1), 165-176.
12. FREIFELD A., MARCHIGIANI D., WALSH T., CHANOCK S., LEWIS L., HIEMENZ J., HIEMENZ S., HICKS J.E., GILL V., STEINBERG S.M., PIZZO P.A. (1999). A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. New Engl. J. Med. 341 (5), 305-311.
13. FULOP T., LARBI A., DOUZIECH N., FORTIN C., GUERARD K.P., LESUR O., KHALIL A., DUPUIS G. (2004). Signal transduction and functional changes in neutrophils with aging. Aging Cell. 3 (4), 217-226.
14. GARCIA-SUAREZ J., KRSNIK I., REYES E., DE MIGUEL D., HERMANZ N., BARR- ALÌ M., BURGALETA C. (2003). Elderly haematological patients with chemotherapy-induced febrile neutropenia have similar rates of infection and outcome to younger adults: a prospective study and risk-adapted therapy. Br. J. Haematol. 120 (2), 209-216.
15. GIRMENIA C., LO COCO F., BRECCIA M., LATAGLIATA R., SPADEA A., D'ANDREA M., GENTILE G., MICOZZI A., ALIMENA G., MARTINO P., MANDELLI F. (2003). Infectious complications in patients with acute promyelocitic leukemia treated with the AIDA regimen. Leukemia 17 (5), 925-930.
16. HAKIM F.T., FLOMERFELT F.A., BOYADZIS M., GRESS R.E. (2004). Aging, immunity and cancer. Curr Opin Immunol. 16 (2), 151-156.
17. KERN W.V., COMETTA A., DE BOCK R., LANGENAEKEN J., PAESMANS M., GAYA H. (1999). Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy intravenous International. Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. New Engl. J. Med. 341 (5), 312-318.
18. MAVOR A.L., THEWES S., HUBE B. (2005). Systemic fungal infections caused by Candida species: epidemiology, infection progress and virulence attributes. Curr. Drug Targets. 6 (8), 863-874.
19. OFFIDANI M., CORVATTA L., MALERBA L., MARCONI M., LEONI P. (2004). Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center. Leuk Lymphoma. 45 (8), 1617-1621.
20. RICHARD P., AMADOR DEL VALLE G., MOREAU P., MILPIED N., FELICE M.P., DAESCHLER T., HAROUSSEAU J.L., RICHET H. (1995). Viridans streptococcal bacteraemia in patients with neutropenia. Lancet. 345, (8965) 1607-1609.
21. ROLSTON K.V., TARRAND J.J. (1999). Pseudomonas aeruginosa - still frequent pathogen in patients with cancer: 11-year experience at a comprehensive cancer Center. Clin. Infect. Dis. 29 (2), 463-464.
22. SUNG L., LANGE B.J., GERBING R.B., ALONZO T.A., FEUSNER J. (2007). Microbiologically documented infections and infections-related mortality in children with acute myeloid leukaemia. Blood 27 (Epub ahead of print).
23. VITALE A., GUARINI A., ARIOLA C., MANCINI M., CUNEO A., PANE F., SAGLIO G., CIMINO G., TAFURI A., MELONI G., FABBIANO F., RECCHIA A., KROPP M.G., KRAMPERA M., CASCAVILLA N., FERRARA F., ROMANO A., MAZZA P., FOZZA C., PAOLONI F., VIGNETTI M., FOÀ R. (2006). Adult T-cell acute lymphoblastic leukemia: biologic profile at presentation and correlation with response to induction treatment in patients enrolled in the GIMEMA LAL 0496 protocol. Blood. 107 (2), 473-479.